Bir sonraki

Otomatik oynatma

MARS: mutation-adjusted risk score for advanced systemic mastocytosis

1 Görünümler • 07/09/23
Pay
gömmek
administrator
administrator
Aboneler
0

Andreas Reiter, MD, University Medical Centre, Mannheim, Germany, discusses how a mutation-adjusted risk score (MARS) may improve treatment stratification for advanced systemic mastocytosis (AdvSM). This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma